Calidi Biotherapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Calidi Biotherapeutics, Inc. (CLDI) reported Basic Shares Outstanding (Weighted Average) of 1.42 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 1.42M shares, a 686.67% increase year-over-year.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.31M shares, a 356.71% increase year-over-year.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 7.12K shares, a 459.47% increase year-over-year.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.91K shares, a 652.61% increase year-over-year.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.30K shares, a 544.98% increase from fiscal 2024.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 667.00 shares, a 99.96% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.69M shares, a 80.18% decline from fiscal 2022.
- Calidi Biotherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 8.51M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.42M shares 10-Q · filed 2026-08-13 | 1.03M shares 10-Q · filed 2026-08-13 | 3.91M shares derived: average of 3 quarters · filed 2026-08-13 | 2.93M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 10.31M shares 10-Q · filed 2026-05-14 | 5.16M shares derived: average of 2 quarters · filed 2026-05-14 | 3.44M shares derived: average of 3 quarters · filed 2026-05-14 | 2.63M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 7.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 6.01K shares derived: average of 2 quarters · filed 2026-03-27 | 64.01K shares derived: average of 3 quarters · filed 2026-08-13 | 4.30K shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 4.91K shares 10-Q · filed 2025-11-13 | 92.45K shares derived: average of 2 quarters · filed 2026-08-13 | 3.36K shares 10-Q · filed 2025-11-13 | 610.79K shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 180.00K shares 10-Q · filed 2026-08-13 | 2.88K shares 10-Q · filed 2025-08-08 | 161.00K shares 10-Q · filed 2026-08-13 | 2.57K shares 10-Q · filed 2025-08-08 | 812.76K shares derived: average of 3 quarters · filed 2026-08-13 | 609.73K shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 2.26M shares 10-Q · filed 2026-05-14 | 27.09K shares 10-Q · filed 2025-05-14 | 1.13M shares derived: average of 2 quarters · filed 2026-05-14 | 752.98K shares derived: average of 3 quarters · filed 2026-05-14 | 564.84K shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | 1.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 962.50 shares derived: average of 2 quarters · filed 2026-03-27 | 789.67 shares derived: average of 3 quarters · filed 2026-03-27 | 667.00 shares 10-K · filed 2026-03-27 | 8.01M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 652.00 shares 10-Q · filed 2025-11-13 | 7.82M shares 10-Q · filed 2024-11-12 | 548.00 shares derived: average of 2 quarters · filed 2025-11-13 | 465.00 shares 10-Q · filed 2025-11-13 | 5.58M shares 10-Q · filed 2024-11-12 | 892.16K shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 444.00 shares 10-Q · filed 2025-08-08 | 5.33M shares 10-Q · filed 2024-08-13 | 370.00 shares 10-Q · filed 2025-08-08 | 4.44M shares 10-Q · filed 2024-08-13 | 1.19M shares derived: average of 3 quarters · filed 2025-08-08 | 1.25M shares derived: average of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | 3.56K shares 10-Q · filed 2025-05-14 | 35.55M shares 10-Q · filed 2024-05-14 | 1.78M shares derived: average of 2 quarters · filed 2025-05-14 | 1.67M shares derived: average of 3 quarters · filed 2025-05-14 | 1.47M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 3.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.50M shares derived: average of 2 quarters · filed 2025-03-31 | 1.96M shares derived: average of 3 quarters · filed 2025-03-31 | 1.69M shares 10-K · filed 2025-03-31 | 16.89M shares 10-K · filed 2024-03-15 | |||
| 2023-09-30 | 1.43M shares 10-Q · filed 2024-11-12 | 14.31M shares 10-Q · filed 2023-11-14 | 1.15M shares derived: average of 2 quarters · filed 2024-11-12 | 1.06M shares 10-Q · filed 2024-11-12 | 10.60M shares 10-Q · filed 2023-11-14 | 4.88M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 878.00K shares 10-Q · filed 2024-08-13 | 872.00K shares 10-Q · filed 2024-08-13 | 6.04M shares derived: average of 3 quarters · filed 2024-08-13 | 6.67M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 8.65M shares 10-Q · filed 2024-05-14 | 8.61M shares derived: average of 2 quarters · filed 2024-05-14 | 8.60M shares derived: average of 3 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | 8.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 8.57M shares derived: average of 2 quarters · filed 2024-03-15 | 8.51M shares 10-K · filed 2024-03-15 | |||||
| 2022-09-30 | 8.57M shares 10-Q · filed 2023-11-14 | 8.48M shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |